Condition
Kidney Transplant Failure and Rejection clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Kidney Transplant Failure and Rejection clinical trials that are recruiting, at sites in 3 countries (most in France (2), Australia (1), United States (1)). By phase: Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Kidney Transplant Failure and Rejection clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Inducing immunological tolerance in kidney transplant patients using stem cell infusion | Phase 1 | Los Angeles, California | Recruiting | Sep 1, 2022 |
| Treating BK Virus Infections in Kidney Transplant Recipients | Phase 3 | Canberra, Australian Capital Territory and 12 other locations | Recruiting | Apr 13, 2022 |
| Investigating tacrolimus metabolism in kidney transplant patients | — | Grenoble, Auvergne-Rhône-Alpes and 1 other locations | Recruiting | Aug 25, 2020 |
| Using Everolimus to Treat Kidney Transplant Patients with Unique Rejection Issues | — | Lyon | Recruiting | May 20, 2019 |
All recruiting trials (4)
-
Inducing immunological tolerance in kidney transplant patients using stem cell infusion
This study is testing whether giving stem cells from the same donor to kidney transplant patients can help them stop taking their immunosuppressive medications safely.
-
Treating BK Virus Infections in Kidney Transplant Recipients
This study is testing if changing the way we manage immune suppression and giving a special treatment can help kidney transplant patients with BK virus infections feel better and keep their transplants healthy.
-
Investigating tacrolimus metabolism in kidney transplant patients
This study looks at how kidney transplant patients process a medication called tacrolimus over four years to see if it affects their kidney health and how genetics might play a role.
-
Using Everolimus to Treat Kidney Transplant Patients with Unique Rejection Issues
This study is testing if the drug Everolimus can help kidney transplant patients who have a specific type of rejection that isn't well understood, to see if it improves their kidney function and overall health.
Related topics
Quick answers
How many Kidney Transplant Failure and Rejection clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in France (2 trials), Australia (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.